In clinical practice, serum CK18‐M65 and CK18‐M30 level concentrations have been employed for diagnostic assessment and disease activity evaluation across a range of liver disorders, as well as in oncology research for tumor monitoring and therapeutic response evaluation [23]. Here, KRT18 is linked to liver disorder.